Efficient incorporation and protection of lansoprazole in cyclodextrin metal-organic frameworks.
Cyclodextrin
Drug stability
Inclusion complex
Lansoprazole
Metal-organic frameworks
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
30 Jul 2020
30 Jul 2020
Historique:
received:
29
04
2020
revised:
14
05
2020
accepted:
15
05
2020
pubmed:
24
5
2020
medline:
4
3
2021
entrez:
24
5
2020
Statut:
ppublish
Résumé
Lansoprazole (LPZ) is an acid pump inhibitor, which readily degrades upon acidic or basic conditions and under heating. We investigated here LPZ stability upon incorporation in particles made of cyclodextrin metal-organic frameworks (CD-MOFs). LPZ loaded CD-MOFs were successfully synthesized, reaching high LPZ payloads of 23.2 ± 2.1 wt%, which correspond to a molar ratio of 1:1 between LPZ and γ-CD. The homogeneity of LPZ loaded CD-MOFs in terms of component distribution was confirmed by elemental mapping by STEM-EDX. Both CTAB, the surfactant used in the CD-MOFs synthesis, and LPZ compete for their inclusion in the CD cavities. CTAB allowed obtaining regular cubic particles of around 5 µm with 15 wt% residual CTAB amounts. When LPZ was incorporated, the residual CTAB amount was less than 0.1 wt%, suggesting a higher affinity of LPZ for the CDs than CTAB. These findings were confirmed by molecular simulations. Vibrational circular dichroism studies confirmed the LPZ incorporation inside the CDs. Solid-state NMR showed that LPZ was located in the CDs and that it remained intact even after three years storage. Remarkably, the CD-MOFs matrix protected the drug upon thermal decomposition. This study highlights the interest of CD-MOFs for the incorporation and protection of LPZ.
Identifiants
pubmed: 32445910
pii: S0378-5173(20)30426-9
doi: 10.1016/j.ijpharm.2020.119442
pii:
doi:
Substances chimiques
Cyclodextrins
0
Drug Carriers
0
Metal-Organic Frameworks
0
gamma-Cyclodextrins
0
Lansoprazole
0K5C5T2QPG
Cetrimonium
Z7FF1XKL7A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
119442Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.